Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines

Journal article

Open access

Peer reviewed

Molecular Therapy, Vol.28(11), pp.2303-2304

2020

PMCID: PMC7546260

PMID: 33065038

Abstract

Adenovirus Vaccines

Animals

Viral Vaccines

Betacoronavirus

COVID-19

COVID-19 Vaccines

Coronavirus Infections

Humans

Pandemics

Pneumonia, Viral

SARS-CoV-2

url

Find in HALView

url

https://doi.org/10.1016/j.ymthe.2020.10.002View

Published (Version of record) Open

1 Record Views

Title: Pros and Cons of Adenovirus-Based SARS-CoV-2 Vaccines
Creators - without role: Eric J Kremer - Université de Montpellier, Institut de Génétique Moléculaire de Montpellier - IGMM
Publication Details: Molecular Therapy, Vol.28(11), pp.2303-2304
Grant note: E.J.K. is an Inserm Fellow and supported by La Fondation pour la Recherche Médicale, Agence National de la Recherche, Université de Montpellier MUSE.
Identifiers: 9937441309311
Academic Unit: Institut de Génétique Moléculaire de Montpellier - IGMM
Language: English
Resource Type: Journal article
Local Fields: hal-04919355